Protas was this week named in a new report exploring how the UK should harness innovation in science and technology in order to safeguard its future.
“A New National Purpose: Innovation Can Power the Future of Britain” is a joint report by Sir Tony Blair and Lord William Hague and part of Future of Britain, a project that seeks to “reinvigorate progressive politics to meet the challenges the UK faces in the decades ahead”.
Across artificial intelligence (AI), biology, the climate and more, the report examines the realities and opportunities of technology and its nexus with science for the UK, including where the country stands as a global player.
Regarding biotechnology, the report states: “The UK is well placed to be at the forefront of [biotech] if it makes the right policy interventions. We are home to leading research institutions, which has translated at times into companies.
“Oxford University’s Martin Landray, whose RECOVERY trial was essential to fighting Covid, is attempting to revolutionise clinical trials through Protas.”
At Protas, we combine smart randomized clinical trial design with effective use of data, technology and collaborative partnerships to deliver cost-effective global trials which increase the pipeline of treatments for common diseases and change clinical practice – on a global scale.
We exist to improve patient care and public health outcomes so that, ultimately, more people around the world can live healthier lives.
We’re therefore delighted to have been cited as a leader in biotech in this report as a symbol of our mission. Read the full report here.